BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kelm NE, Zhu Z, Ding VA, Xiao H, Wakefield MR, Bai Q, Fang Y. The role of IL-29 in immunity and cancer. Crit Rev Oncol Hematol 2016;106:91-8. [PMID: 27637354 DOI: 10.1016/j.critrevonc.2016.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Mertowska P, Mertowski S, Smarz-Widelska I, Grywalska E. Biological Role, Mechanism of Action and the Importance of Interleukins in Kidney Diseases. Int J Mol Sci 2022;23:647. [PMID: 35054831 DOI: 10.3390/ijms23020647] [Reference Citation Analysis]
2 Falkowski B, Szczepanek-Parulska E, Krygier A, Wrotkowska E, Ruchala M. Evaluation of interleukin-29 in autoimmune and inflammatory thyroid diseases. Clin Endocrinol (Oxf) 2021;94:998-1003. [PMID: 33449383 DOI: 10.1111/cen.14418] [Reference Citation Analysis]
3 D'mello KP, Zhao L, Kaser EC, Zhu Z, Xiao H, Wakefield MR, Bai Q, Fang Y. The role of interleukins and the widely studied TNF-α in non-Hodgkin's lymphoma. Med Oncol 2021;38:56. [PMID: 33835307 DOI: 10.1007/s12032-021-01504-y] [Reference Citation Analysis]
4 Peng Q, Luo A, Zhou Z, Xuan W, Qiu M, Wu Q, Xu L, Kong X, Zhang M, Tan W, Xue M, Wang F. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1. Cytokine 2019;113:144-54. [DOI: 10.1016/j.cyto.2018.06.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hawerkamp HC, Domdey A, Radau L, Sewerin P, Oláh P, Homey B, Meller S. Tofacitinib downregulates antiviral immune defence in keratinocytes and reduces T cell activation. Arthritis Res Ther 2021;23:144. [PMID: 34020693 DOI: 10.1186/s13075-021-02509-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Iwaszko M, Biały S, Bogunia-Kubik K. Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis. Cells 2021;10:3000. [PMID: 34831223 DOI: 10.3390/cells10113000] [Reference Citation Analysis]
7 Al-Nesf MAY, Abdesselem HB, Bensmail I, Ibrahim S, Saeed WAH, Mohammed SSI, Razok A, Alhussain H, Aly RMA, Al Maslamani M, Ouararhni K, Khatib MY, Hssain AA, Omrani AS, Al-Kaabi S, Al Khal A, Al-Thani AA, Samsam W, Farooq A, Al-Suwaidi J, Al-Maadheed M, Al-Siddiqi HH, Butler AE, Decock JV, Mohamed-Ali V, Al-Ejeh F. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications. Nat Commun 2022;13:946. [PMID: 35177642 DOI: 10.1038/s41467-022-28639-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dhiman G, Abraham R, Griffin DE. Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus. Sci Rep 2019;9:9951. [PMID: 31289325 DOI: 10.1038/s41598-019-46389-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
9 Wang P, Fu Y, Chen Y, Li Q, Hong Y, Liu T, Ding Z. Nomogram Personalizes and Visualizes the Overall Survival of Patients with Triple-Negative Breast Cancer Based on the Immune Genome. Biomed Res Int 2020;2020:4029062. [PMID: 33299869 DOI: 10.1155/2020/4029062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Lin TY, Chiu CJ, Kuan CH, Chen FH, Shen YC, Wu CH, Hsu YH. IL-29 promoted obesity-induced inflammation and insulin resistance. Cell Mol Immunol 2020;17:369-79. [PMID: 31363171 DOI: 10.1038/s41423-019-0262-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
11 Falkowski B, Szczepanek-Parulska E, Sawicka-Gutaj N, Krygier A, Ruchala M. Evaluation of IL-29 in Euthyroid Patients with Graves' Orbitopathy: A Preliminary Study. Mediators Inflamm 2020;2020:4748612. [PMID: 32694926 DOI: 10.1155/2020/4748612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Wang JM, Huang AF, Xu WD, Su LC. Insights into IL-29: Emerging role in inflammatory autoimmune diseases. J Cell Mol Med 2019;23:7926-32. [PMID: 31578802 DOI: 10.1111/jcmm.14697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 Xu DH, Zhu Z, Xiao H, Wakefield MR, Bai Q, Nicholl MB, Ding VA, Fang Y. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma. Cancer Lett 2017;394:43-51. [PMID: 28254411 DOI: 10.1016/j.canlet.2017.02.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
14 Mikola E, Elenius V, Saarinen M, Palomares O, Waris M, Turunen R, Puhakka T, Ivaska L, Rückert B, Aab A, Vahlberg T, Vuorinen T, Allander T, Camargo CA Jr, Akdis M, Akdis CA, Jartti T. Tonsillar cytokine expression between patients with tonsillar hypertrophy and recurrent tonsillitis. Clin Transl Allergy 2018;8:22. [PMID: 29942488 DOI: 10.1186/s13601-018-0205-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
15 Bassaro L, Russell SJ, Pastwa E, Somiari SA, Somiari RI. Screening for Multiple Autoantibodies in Plasma of Patients with Breast Cancer. Cancer Genomics Proteomics 2017;14:427-35. [PMID: 29109092 DOI: 10.21873/cgp.20052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
16 Fallah Vastani Z, Ahmadi A, Abounoori M, Rouhi Ardeshiri M, Masoumi E, Ahmadi I, Davodian A, Kaffashian M, Kenarkoohi A, Falahi S, Mami S, Mami S. Interleukin-29 profiles in COVID-19 patients: Survival is associated with IL-29 levels. Health Sci Rep 2022;5:e544. [PMID: 35284646 DOI: 10.1002/hsr2.544] [Reference Citation Analysis]
17 Pires IS, Hammond PT, Irvine DJ. Engineering Strategies for Immunomodulatory Cytokine Therapies - Challenges and Clinical Progress. Adv Ther (Weinh) 2021;4:2100035. [PMID: 34734110 DOI: 10.1002/adtp.202100035] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]